rs6748672
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_032601.4(MCEE):c.311G>T(p.Arg104Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.173 in 1,613,596 control chromosomes in the GnomAD database, including 25,168 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_032601.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCEE | NM_032601.4 | c.311G>T | p.Arg104Leu | missense_variant | 2/3 | ENST00000244217.6 | NP_115990.3 | |
MCEE | XM_047446039.1 | c.311G>T | p.Arg104Leu | missense_variant | 2/3 | XP_047301995.1 | ||
MCEE | XM_005264613.3 | c.216+95G>T | intron_variant | XP_005264670.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MCEE | ENST00000244217.6 | c.311G>T | p.Arg104Leu | missense_variant | 2/3 | 1 | NM_032601.4 | ENSP00000244217 | P1 | |
MCEE | ENST00000486135.1 | c.26G>T | p.Arg9Leu | missense_variant | 3/3 | 3 | ENSP00000441569 | |||
MCEE | ENST00000494660.6 | c.26G>T | p.Arg9Leu | missense_variant | 2/2 | 2 | ENSP00000437361 | |||
MCEE | ENST00000413592.5 | c.84+95G>T | intron_variant | 2 | ENSP00000391140 |
Frequencies
GnomAD3 genomes AF: 0.182 AC: 27671AN: 152066Hom.: 2675 Cov.: 33
GnomAD3 exomes AF: 0.171 AC: 43015AN: 251120Hom.: 3898 AF XY: 0.173 AC XY: 23463AN XY: 135782
GnomAD4 exome AF: 0.172 AC: 252075AN: 1461412Hom.: 22488 Cov.: 33 AF XY: 0.173 AC XY: 125908AN XY: 727016
GnomAD4 genome AF: 0.182 AC: 27690AN: 152184Hom.: 2680 Cov.: 33 AF XY: 0.178 AC XY: 13259AN XY: 74418
ClinVar
Submissions by phenotype
Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency Benign:3
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 26, 2013 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 17% of total chromosomes in ExAC - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at